Earnings call transcript: Italgas Q2 2025 shows strong growth amid market changes

Italgas SpA delivered robust financial performance in H1 2025, with revenues up nearly 30%, adjusted EBITDA increasing 27.8% to €178.8 million, and net profit growing 31%, largely driven by the successful integration of DuiRetegas. Despite these strong results and confirmed BBB+ credit ratings, the stock experienced a modest 0.56% decline, reflecting broader market conditions and ongoing regulatory uncertainties within the Italian gas distribution sector. The company anticipates accelerated synergies from the integration and expects to secure five tender awards by year-end, leveraging new evaluation criteria focused on innovation and digitization, while navigating potential regulatory shifts and asset disposals.

Analysis

Italgas SpA reported a robust first half for 2025, driven by the successful Q2 consolidation of DuiRetegas. Key financial metrics showed significant growth, with revenue increasing nearly 30%, adjusted EBITDA rising 27.8% to €178.8 million, and net profit growing 31% to €360 million. The rapid 90-day integration of DuiRetegas was a key operational success, leading management to guide for synergies at the "super high end" of expectations for 2025. This strong performance, alongside organic RAB growth, more than offset the negative impact of a WACC reduction. Despite these positive results, the stock declined 0.56%, reflecting market caution regarding broader economic conditions and regulatory uncertainty in the Italian gas sector. The company solidified its financial position by completing a €1.02 billion capital increase to finance the acquisition, leading to a confirmation of its BBB+ credit rating. Looking forward, management is focused on securing five gas tender awards by year-end, viewing the shift in evaluation criteria towards innovation and digitization as a competitive advantage, while preparing for the introduction of a new TOTEX regulatory system in 2028.

Key Decisions for Investors

• The rapid and successful integration of DuiRetegas significantly de-risks the acquisition and suggests upside potential to the guided €200 million synergy target, so investors should monitor upcoming quarterly results for evidence of accelerated cost savings.
• Regulatory developments remain the key risk and catalyst; investors must closely track updates from the Italian regulator on the 2028 TOTEX system and tender framework changes, as these will directly dictate long-term return on capital.
• Consider the stock's 5.06% dividend yield and strong free cash flow generation, which present a compelling income case, balanced against the aforementioned regulatory overhang and muted market reaction to strong earnings.
• Near-term performance will be influenced by the outcome of five expected tender awards by year-end and the completion of the mandatory asset disposal process by mid-November, which will test the company's competitive positioning and capital discipline.